Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nighttime Moisturizing Balm for Atopic Dermatitis in Infants
NCT02404493Terminated
- Sponsor
- Johnson & Johnson
- Start
- Mar 2015
- Primary completion
- Mar 2016
- Modality
- Transdermal Patches, Hydrogel Systems, Classical Binding Small Molecules
- Countries
- 1
01
Overview
Randomised trial of colloidal oatmeal in atopic dermatitis (AD) (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Change From Baseline in Mean Corneometer Measurement at Day 14. Started Mar 2015; status: terminated.
02
Drugs
colloidal oatmeal
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02404493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02404493.